Jeffrey Balser Net Worth

The estimated Net Worth of Jeffrey R. Balser is at least 368 千$ dollars as of 16 February 2021. Jeffrey Balser owns over 1,225 units of Varian Medical Systems stock worth over 46,695$ and over the last 6 years he sold VAR stock worth over 0$. In addition, he makes 321,195$ as Independent Director at Varian Medical Systems.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Jeffrey Balser VAR stock SEC Form 4 insiders trading

Jeffrey has made over 3 trades of the Varian Medical Systems stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 1,225 units of VAR stock worth 20,255$ on 16 February 2021.

The largest trade he's ever made was exercising 1,243 units of Varian Medical Systems stock on 13 February 2020 worth over 20,553$. On average, Jeffrey trades about 217 units every 35 days since 2018. As of 16 February 2021 he still owns at least 2,824 units of Varian Medical Systems stock.

You can see the complete history of Jeffrey Balser stock trades at the bottom of the page.

Jeffrey Balser biography

Dr. Jeffrey R. Balser M.D. Ph.D. serves as Independent Director of the Company. President and Chief Executive Officer of Vanderbilt University Medical Center (May 2016—present) • ?Dean, Vanderbilt University School of Medicine (October 2008—present) • ?Vice Chancellor for Health Affairs, Vanderbilt University Medical Center (June 2009—April 2016) • ?Associate Vice Chancellor for Research, Vanderbilt University Medical Center (January 2004—October 2008).

What is the salary of Jeffrey Balser?

As the Independent Director of Varian Medical Systems, the total compensation of Jeffrey Balser at Varian Medical Systems is 321,195$. There are 4 executives at Varian Medical Systems getting paid more, with Dow Wilson having the highest compensation of 9,446,300$.

How old is Jeffrey Balser?

Jeffrey Balser is 57, he's been the Independent Director of Varian Medical Systems since 2018. There are 7 older and 5 younger executives at Varian Medical Systems. The oldest executive at Varian Medical Systems, Inc. is David Illingworth, 66, who is the Independent Director.

What's Jeffrey Balser's mailing address?

Jeffrey's mailing address filed with the SEC is 3657 Richland Ave, Nashville, TN 37205, USA.

Insiders trading at Varian Medical Systems

Over the last 22 years, insiders at Varian Medical Systems have traded over 57,574,967$ worth of Varian Medical Systems stock and bought 500 units worth 22,595$ . The most active insiders traders include Kent J Thiry、Timothy E Guertin、Dow R Wilson. On average, Varian Medical Systems executives and independent directors trade stock every 11 days with the average trade being worth of 181,124$. The most recent stock trade was executed by Jesse Michael Bruff on 1 March 2021, trading 6,499 units of VAR stock currently worth 1,142,589$.

What does Varian Medical Systems do?

Complete history of Jeffrey Balser stock trades at CVS Health Corp、Varian Medical Systems

Varian Medical Systems executives and stock owners

Varian Medical Systems executives and other stock owners filed with the SEC include:

• Dow Wilson,
  Chief Executive Officer, Director
• Kolleen Kennedy,
  President - Proton Solutions Division and Chief Growth Officer
• Chris Toth,
  President, Chief Operating Officer
• R. Andrew Eckert,
  Independent Chairman of the Board
• Jeffrey Balser,
  Independent Director
• Judy Bruner,
  Independent Director
• Anat Ashkenazi,
  Independent Director
• Jean-Luc Butel,
  Independent Director
• Regina Dugan,
  Independent Director
• David Illingworth,
  Independent Director
• Phillip Febbo,
  Independent Director
• Michael Hutchinson,
  Senior Vice President, Chief Legal Officer
• Francis Facchini,
  President, Interventional Solutions Business
• Anshul Maheshwari,
  Vice President, Treasurer and Investor Relations
• Michelle Le Beau,
  Independent Director
• J. Michael Bruff,
  Chief Financial Officer, Senior Vice President - Finance
• Magnus Momsen,
  SVP, CAO, Corporate Controller
• Mark R Laret,
  Director
• Jose Baselga,
  Director
• John W Kuo,
  SVP, Gen Counsel and Secretary
• Gary E Jr Bischoping,
  SVP, Finance & CFO
• Susan L Bostrom,
  Director
• Timothy E Guertin,
  Director
• Clarence R Verhoef,
  SVP, Finance, Corp Controller
• Venkatraman Thyagarajan,
  Director
• Sunny Sanyal,
  SVP and President, ICB
• Robert H Kluge,
  Corporate Vice President
• Richard M Levy,
  President and CEO
• Ruediger Naumann Etienne,
  Director
• John Seely Brown,
  Director
• Erich R Reinhardt,
  Director
• Tai Yun Chen,
  VP and Corporate Controller
• David W Jr Martin,
  Director
• Steven A Leibel,
  Director
• Kent J Thiry,
  Director
• Allen S Lichter,
  Director
• Samuel Hellman,
  Director
• Crisanto C Raimundo,
  Corporate Controller
• Terry R Lautenbach,
  Director
• Joseph B Phair,
  VP Admin,Gen Counsel,Secretary
• Elisha W Finney,
  Corporate Vice President & CFO
• Kevin O'reilly,
  SVP, President of Oncology Sys